医学
前部缺血性视神经病变
赛马鲁肽
视神经病变
眼科
兴奋剂
视神经
糖尿病
内科学
受体
2型糖尿病
利拉鲁肽
内分泌学
作者
Jimena Tatiana Hathaway,Madhura Shah,David Hathaway,Seyedeh M. Zekavat,Drenushe Krasniqi,John W. Gittinger,Dean M. Cestari,Robert M. Mallery,Bardia Abbasi,Marc A. Bouffard,Bart K. Chwalisz,Tais Estrela,Joseph F. Rizzo
出处
期刊:JAMA Ophthalmology
[American Medical Association]
日期:2024-07-03
卷期号:142 (8): 732-732
被引量:72
标识
DOI:10.1001/jamaophthalmol.2024.2296
摘要
Anecdotal experience raised the possibility that semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA) with rapidly increasing use, is associated with nonarteritic anterior ischemic optic neuropathy (NAION).
科研通智能强力驱动
Strongly Powered by AbleSci AI